Discovery of Fused Triazolo-thiadiazoles as Inhibitors of TNF-alpha: Pharmacophore Hybridization for Treatment of Neuropathic Pain

Abstract

IntroductionNeuropathic pain is a complex, chronic pain state that is usually accompanied by tissue injury. With neuropathic pain, the nerve fibers themselves may be damaged, dysfunctional, or injured.MethodsA series of pharmacophoric hybrids of substituted aryl semicarbazides incorporated into a fused triazolo-thiadiazole nucleus were synthesized and evaluated for neuropathic pain activity. After the assessment of neurotoxicity and peripheral analgesic activity, the compounds were evaluated in two peripheral neuropathic pain models, the chronic constriction injury and partial sciatic nerve ligation, to assess their antiallodynic and antihyperalgesic potential.ResultsSelected compounds exhibiting promising efficacies (4b, 6a, and 7e) revealed median effective dose (ED50) values ranging from 7.62–28.71 mg/kg in four behavioral assays of allodynia and hyperalgesia (spontaneous pain, tactile allodynia, cold allodynia, and mechanical hyperalgesia). Studies carried out to assess the underlying mechanism revealed that compounds suppressed the inflammatory component of the neuropathic pain by inhibiting tumor necrosis factor (TNF)-alpha and preventing oxidative and nitrosative stress.ConclusionUsing a hybrid design approach, the present study identified novel chemical compounds that could be a potential lead for the treatment of neuropathic pain.

Adaptive Response of T and B Cells in Atherosclerosis

“…147,148 Interestingly, methotrexate showed high activity against atherosclerosis in animal models, 149,150 suggesting that it may induce clinical benefits in the general human population. Similarly, TNF blockade, of which is also a standard therapy for autoimmune diseases, 151 has been linked to decreased CVD risk in rheumatoid arthritis. 152,153 T cells, particularly the naïve, depend highly on costimulation to be activated.…”

Modulation of Autoimmunity and Atherosclerosis – Common Targets and Promising Translational Approaches Against Disease –

“…Various anti-TNF drugs are indicated for more than 15 diseases, including other classical autoimmune diseases, such as ankylosing spondylitis, psoriasis, and psoriatic arthritis. 36 Notably, anti-TNF therapy is associated with lower CVD risk in RA 37,38 and psoriatic patients. 39 Experimentally, TNF blockade in vivo suppresses neointimal formation in the coronary arteries of transplanted hearts, 40 but not following balloon angioplasty in rabbits.…”

Microwave-assisted synthesis and pharmacological screening of some triazolothiadiazole derivatives

“…The observed antinociceptive activities in all the tests such as hot-plate, tail-clip, tail flick and acetic acidinduced writhing tests clearly showed that mechanical, thermal and chemical nociceptive pathways had a role on their pharmacological effects (Sharma et al, 2012). Hotplate and tail-clip tests have been reported as a measure of centrally mediated transient pain (Gabra, Sirois, 2003;Wong et al, 1994).…”